ABSTRACT
BACKGROUND: The coronavirus disease (COVID-19) pandemic brought the virtual interview (VI) format to graduate medical education (GME) and the trainee recruitment process. It is unclear if applicants' VI experience is consistent across all demographic groups. Our group collected 2 years of survey data to assess longitudinal changes in applicants' attitudes towards the VI format. In addition, demographic data were collected, and analyses were performed to identify if between-group differences were present amongst a diverse applicant population. METHODS: We distributed an anonymous electronic survey to applicants to the pulmonary disease and critical care medicine fellowship programs at Case Western Reserve University/University Hospitals Cleveland Medical Center and MetroHealth Medical Center for the 2021 and 2022 appointment years. RESULTS: We received 112 responses (20% response rate) for our surveys. Although there was an overall stability of responses between the first 2 years, there were significant gender differences with applicants identifying as female more likely to recommend VI as a future model. Similarly, there were a significant difference in factor importance based on underrepresented minority (URM) status with applicants identifying as URM placing more emphasis on programs' social media presence. CONCLUSIONS: There were no significant change in the responses of applicants between the first 2 years of VI. However, subset analyses revealed multiple significant findings. These differences have implications for future iterations of the VI format.
Subject(s)
COVID-19 , Internship and Residency , Humans , Female , COVID-19/epidemiology , Academic Medical Centers , Education, Medical, Graduate , Electronics , Fellowships and ScholarshipsABSTRACT
B Introduction: b Granulomatosis with polyangiitis (GPA) is a rare anti-neutrophil cytoplasmic autoantibody (ANCA) (primarily anti-protease 3 [PR3])-associated vasculitis, usually affecting small to medium vessels in the upper and lower respiratory tract and kidneys. A kidney biopsy confirmed the diagnosis of GPA and the patient was started on rituximab. In this case, the diagnosis of COVID-19 confounded the diagnosis of GPA. [Extracted from the article] Copyright of Critical Care Medicine is the property of Lippincott Williams & Wilkins and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)